Search Weight Loss Topics:

Page 3,020«..1020..3,0193,0203,0213,022..3,0303,040..»

Weight loss operations up by 12%

Posted: February 23, 2012 at 1:36 pm

The number of weight loss operations has risen 12% while hospital admissions for obesity have also jumped.

In 2010/11, there were 8,087 weight loss stomach operations in England's hospitals, up from 7,214 in 2009/10, according to data from the NHS Information Centre.

The report highlights around a 30-fold increase in the number of people going under the knife in the last decade, from just 261 weight loss operations in 2000/01.

Recent figures include operations to adjust an existing gastric band rather than fit a new one. Of the 8,087 procedures in 2010/11, 1,444 were for maintenance of an existing band. Bariatric weight loss surgery includes stomach stapling, gastric bypasses and a procedure called sleeve gastrectomy.

The report also found a dramatic rise in the number of hospital admissions for patients whose main diagnosis was obesity.

Over the last decade, these admissions have risen from 1,054 in 2000/01 to 11,574 in 2010/11. Admissions among women are almost three times higher than for men - 8,654 in 2010/11 compared with 2,919 for men.

The North East has the highest rate of admissions with a primary diagnosis of obesity (40 per 100,000 of the population), followed by the East Midlands (36 per 100,000) and London (35 per 100,000). The South West, south central and North West have the lowest rates, with 14 admissions for every 100,000 people.

Weight loss surgery was most common in the East Midlands (32 procedures for every 100,000 people) and least common in the North West (six per 100,000). The figure in the east of England and south central regions was nine procedures for every 100,000 population.

Chief executive of the NHS Information Centre Tim Straughan said: "The report charts the growing impact of obesity on both people's health and NHS resources. It also examines changes in physical activity and diet. Those working in this field may want to examine closely the findings of the report, including the significant regional variations that appear to exist in both the admissions for obesity and those for weight loss stomach surgery."

A Department of Health spokesman said: "We want people to live healthier lives so they do not need to resort to surgery. We are working with charities, local government and industry to make it easier for people to make better choices. This year a third of meals and takeaways served from popular high street chains will contain calorie information and over a million families are involved in our Change4Life campaign - helping people to eat well and move more."

Read more here:
Weight loss operations up by 12%

VIDEO: Star Jones Returns to The View, Faces Questions About Controversial Exit, Weight Loss

Posted: February 23, 2012 at 1:35 pm

The View

Star Jones returned to The View Wednesday, almost six years after she left the show under unpleasant circumstances.

"It was ugly, everything around was ugly," Jones, 49, observed. "It was a bad, emotional time. Nasty things were being said in the media. It was just not a good emotional time." Jones, who was on the show to promote women's heart health, seemed surprised by Walters' line of questioning about her controversial exit. "I had eight fantastic years here. One was 'eh,'" she said. "I came back to congratulate you on all you accomplished. I hope you congratulate me on what I accomplished."

Check out photos from The View

In 2006, View creator and co-host Barbara Walters revealed to Jones that her contract would not be renewed for a 10th season, and said Jones could say that it was her decision. Jones then announced on the show that she would be leaving, but told People magazine that she felt like she was "fired." The following day, Walters informed viewers that Jones would no longer be a part of the show effective immediately, and her name was quickly removed from the show's credits and from its official website.

"I take real responsibility for my own behavior at all times, but I won't take responsibility if have not made a decision I can live with. I made the decision to go out on my own terms," Jones said. "I wanted to be able to control it so when I walk back in here, if I were ever invited, I would feel good about coming in."

Watch more videos from The View

Walters and Joy Behar also asked Jones about her 2003 gastric bypass surgery. At the time, Jones refused to confirm she had undergone the procedure, despite her subsequent 160 pound weight loss. "We tried to protect you. We were told, 'Don't say it was gastric [bypass]. Say it was pilates and portion control,' " Behar said. "You are now a skinny b---. Congratulations."

Added Walters: "We did lie for you!"

Watch the full semi-awkward exchange below:

What do you think of Jones' reason for leaving? Do you miss seeing her on The View?

See the rest here:
VIDEO: Star Jones Returns to The View, Faces Questions About Controversial Exit, Weight Loss

New science can help guide diets and exercise

Posted: February 23, 2012 at 1:35 pm

The most important weight-loss message - you have to use more calories than you eat - hasn't changed in decades.

But dieting experts say science has some new, surprising things to say about the other half of the standard recommendation - exercise - and about which diet to use.

Researchers are also refining the behavioral tricks that can change the way people eat, not only to lose weight but also to keep it off. Modern technology is giving dieters new options, such as Internet- and cell-phone-based programs or scales that can transmit your weight from your home to your doctor or dietitian.

Thomas Wadden, director of the Center for Weight and Eating Disorders at the University of Pennsylvania, said the last decade has seen "pretty aggressive diet wars" among the proponents of low-fat, low-carb, or low-glycemic-index approaches.

After years of comparisons, Wadden and other experts said the verdict is clear: What you choose doesn't matter. Pick a diet you can stick to, including liquid diets or prepared meals. If you follow the rules, the results are all about the same. Wadden said he does recommend that, whatever the diet, patients reduce saturated fats and trans-fats for better health. You can pick a more aggressive approach while you're losing, eventually transitioning to a diet rich in vegetables, fruits, and lean protein for maintenance.

Gary Foster, director of Temple University's Center for Obesity Research, thinks diet gurus have scared people off with too much information. "We tell people so much stuff, it's paralyzing," he said.

He agreed that the specific diet doesn't matter. "Calories drive weight loss," he said.

To lose a pound a week, a dieter needs to eat 500 fewer calories a day. That's simple enough, but your maintenance needs come down as people get smaller. That explains why weight loss gets harder as you go. Think of your body as a house. It takes more energy to heat a big house than a small one. A woman who weighs 300 pounds maintains her weight on about 3,000 calories. (Because they have more muscle, men use a few more.) A woman who weighs 140 needs only 2,050 calories to stay there. Caloric needs drop further as we age and lose muscle mass.

Cheryl Marco, a registered dietitian who runs Thomas Jefferson University's weight management program, starts patients on a prepackaged diet that includes shakes and bars. Dieters have few options.

"Fewer choices work better," Marco said. "What works is the narrowing of stimuli." So her most successful long-term dieters eat meals that don't vary much from day to day.

Some people may just have to stay away from foods that trigger overeating.

"I am not of the belief . . . that we have the ability to learn to eat high-risk foods in moderation," Marco said. Your high-risk food may be ice cream. Someone else's may be fettuccine Alfredo.

John McAroy, 38, dropped 70 pounds (from 300 on a 6-foot-2 frame) between Thanksgiving and early February using Marco's method. He hasn't cheated much and hasn't missed having more choices. "You'd be surprised," he said. "I'm rarely hungry."

So what about exercise? Isn't it the answer?

No, the experts said.

Exercise is "the single best predictor of who keeps weight off and who doesn't," Foster said. "It has very little effect on weight loss."

Exercise can help people lose weight, but so slowly that most people lose interest, he said. It's easier for most people to cut 500 calories out of their diet a day than to burn an extra 500 calories. You have to walk five miles to do that.

What exercise does do is help people maintain muscle mass, which revs up metabolism a little and improves overall health. Still, adding five pounds of muscle takes a lot of work, and a pound of muscle burns only about 15 calories a day.

In one of the cruel twists of our evolutionary history - the one that shaped our bodies to withstand famine, not a world full of junk food - people who have lost a lot of weight burn fewer calories during exercise than people who have never dieted. "It's as if your body's gone green on you," Wadden said. To keep weight off, dieters need to exercise 225 to 300 minutes a week: about 32 to 43 minutes a day.

Foster's group is looking at whether getting a good night's sleep affects weight loss. People who weigh more tend to sleep less, but it's not yet known whether sleeping more helps people lose weight.

On the behavioral front, researchers say that "accountability" is a crucial factor in making diets work. People do best when they keep track of what they eat and how much they exercise. They need to weigh themselves frequently, ideally every day. It also helps a lot to report what they're doing to someone else. The gold standard is a face-to-face meeting, but results also improve with telephone and Internet reporting.

"It's really important to be accountable to somebody else," Foster said.

It's also important to act quickly when the numbers on the scale start moving up. Experts recommend having an action plan when weight rises by two to four pounds - perhaps returning to more intensive monitoring of food intake - and when dieters fall off the wagon.

"One of the major differences between the average-weight person and the overweight person is the ability to recover from overeating," Marco said.

Wadden says technology is offering new alternatives to people who need to lose weight. While not yet in wide use for weight control, scales that transmit weights to doctors or diet programs can build in accountability. Internet- and phone-based programs make it easier to calculate calories and energy usage.

Continued here:
New science can help guide diets and exercise

Fast Money Opportunity but Only if You're Nimble

Posted: February 23, 2012 at 1:35 pm

On Thursday, the Fast Money traders are expecting a big move from this stock. Is it on your radar?

Specifically, the pros are watching Vivus

[VVUS  Loading...      ()   ] after the company received a favorable ruling on its weight loss drug Qnexa. Back in 2010, the FDA rejected Qnexa because of safety concerns.

As bullish as that catalyst is – pro trader Guy Adami sees another reason for the stock to surge.

“There’s something like 20% short interest in Vivus,” he explains. “Expect the shorts to get squeezed. As a result the jump in this stock may be larger than anticipated."

And that’s where the trading opportunity comes in – but you have to be nimble. The Fast traders thinks the stock could overshoot to the upside.

“The stock could over pop early and then have a really big pullback,” says Pete Najarian. In other words if there's an extreme move trade accordingly.

Qnexa, which combines the appetite suppressant phentermine and anti-seizure drug topiramate, helped patients lose at least 10 percent of their weight after a year of treatment, the company said.

The FDA has not approved a new obesity drug since 1999.

Current DateTime: 04:40:11 23 Feb 2012
LinksList Documentid: 26256943

Current DateTime: 04:40:11 23 Feb 2012
LinksList Documentid: 26256941

______________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment, but not have it published on our Web site, send those e-mails to

Trader disclosure: On Feb 22, 2012, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s "Fast Money" were owned by the "Fast Money" traders; Najarian is long AAPL; Najarian is long C; Najarian is long YHOO; Najarian is long HPQ; Najarian is long MOS; Najarian is long SCCO; Najarian is long COP; Najarian is long PFE; Najarian is long MRK; Adami is long C; Adami is long GS; Adami is long INTC; Adami is long MSFT; Adami is long NUE; Adami is long BTU; Adami is long AGU

For Ron Insana
No disclosures

For Mike Khouw
No disclosures

For Doug Kass
Kass is short SPY common and calls
Kass is short QQQ
Kass is short IWM
Kass is short EFA

For Amelia Bourdeau
No disclosures

CNBC.com with wires.

© 2012 CNBC.com

More:
Fast Money Opportunity but Only if You're Nimble

The New 'Old' Idea on Looking Young and Sexy

Posted: February 22, 2012 at 11:12 pm

SAN JOSE, Calif., Feb. 22, 2012 /PRNewswire/ -- From various diets and exercise routines to complicated medical procedures such as Botox and liposuction - people go to great lengths to look better, younger and sexier. Alex Guberman, the owner of the new upscale hair salon Exclussif in San Jose, California, has a different, much simpler and more affordable idea: new hairstyle! It's a much easier and faster solution to transfer yourself into a new, sexier and younger you.

"I don't think people realize how much their hair and makeup can affect their look," says Guberman. "You can make your nose appear smaller, your eyes look larger, your skin more glowing, your cheeks perkier and your smile shinier simply by changing the style, cut and color of your hair."

Guberman opened his new salon last year by partnering up with award-winning stylist Michael Yocum, a former Joico platform artist and a recipient of multiple hair color, styling and cutting awards over the last three decades. Yocum enjoys his work and it shows. "When a customer leaves my chair," says Yocum, "I give them more than just a hair style - I give them confidence, youth and character."

In only a few months of its grand opening, Salon Exclussif is already one of the top-rated salons on Yelp with a growing number of five-star reviews. Salon customers rave about the salon stylists' abilities to perform top-quality work on different types of hair, transforming their customers' images and looks. Services range from deep conditioning, blow dry and style items, all the way to keratin treatments, color and highlights, facial waxing, makeup, and many other services. All new clients receive a free consultation where they work with salon stylists on designing their new look and a plan on its proper maintenance.

Salon Exclussif is an exclusive Joico salon that not only carries a full Joico retail line but uses the Joico products on all of the clients.

Salon Exclussif, a member of Silicon Valley Chamber of Commerce, is also giving back. Five percent of all service revenues are automatically donated to a charity of each customer's choice. The choices of charities for Salon Exclussif customers include Silicon Valley Humane Society, Red Cross - Bay Area Chapter, as well as American Cancer Society and Our City Forest. Salon Exclussif is also a place where customers can donate their hair to Locks of Love - a non-profit organization that provides hairpieces to financially disadvantaged children suffering from long-term medical hair loss.

Visit http://www.exclussif.com for more information, featured video and Yelp reviews, or call 408-377-0100. Salon is located at 2039 Woodard Rd., in the Cambrian area of San Jose, CA.

Contact:

Alex Guberman
Salon Exclussif
408-377-0100

 

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

Read more from the original source:
The New 'Old' Idea on Looking Young and Sexy

Darfur patrol returns home safely after rebel blockade

Posted: February 22, 2012 at 11:12 pm

Home > News > world-news

Al-Fashir, Darfur, Feb 22 : A 55-person patrol of the United Nations-African Union peacekeeping force in Darfur returned to its home base on Tuesday after the team had been blockaded for nearly two days by armed rebels in the northwest of the troubled Sudanese region.

The mission (UNAMID) said ?a show of force and round-the-clock negotiations? resolved the incident after members of the rebel Justice and Equality Movement (JEM) blocked the patrol and later held two UNAMID language assistants and a police adviser.

?Our officers and their troops demonstrated true resolve, courage and compassion,? said Ibrahim Gambari, the head of UNAMID and the Joint Special Representative of the UN and AU in Darfur, which has been beset by fighting and large-scale displacement since 2003.

?Our troops held their ground; they called in reinforcements and they refused to leave the area without all personnel back on the patrol, including the Yemeni police adviser and two Sudanese language assistants. This afternoon everyone has returned, without injury and without any conditionality.?

The incident began on Sunday when the contingent ? comprising 50 Senegalese troops, three police advisers and two language assistants ? was blocked by more than 100 JEM members in the village of Shegeg Tova as it was carrying out a long-range patrol from its team site in Umm Baru.

The UNAMID troops then refused to leave until the two language assistants and the police adviser were released.

The stand-off ended after ?substantial peacekeeping reinforcements? were sent by the mission, which also made repeated contact with the leadership of JEM.

?Our peacekeepers criss-cross Darfur every day to help bring security to civilians who continue to suffer the effects of conflict,? Gambari said.

?We have a mandate to execute in all parts of Darfur. At the same time we are supporting an ongoing and inclusive peace process, including implementation of the Doha Document for Peace in Darfur. This deplorable action taken by JEM contradicts the spirit of this peace process, which most people in Darfur are welcoming.? (IBNS)

Share this article at

 

 

Yearly Horoscope of 2012 for the Zodiac Sign:

 

Sagittarius     Scorpio     Libra    Virgo    Leo     Cancer     Gemini     Taurus     Aries     Pisces     Aquarius     Capricon

 

 

TOP READ ARTICLES:

Lea Michele dating Cory Monteith
Olivier Martinez opening restaurant in Miami
Mariah Carey pays touching YouTube tribute to Whitney Houston
Helen Flanagan vows to cover up 'embarrassing' boobs
Emma Watson success after 'Potter' down to tackling life's simple things
Man dresses up as Wayne Rooney at Rio Carnival
Drew Barrymore wants 'timeless' wedding dress
Antonio Banderas set to play Pablo Picasso
Whitney Houston's lawyer says Bobby Brown broke agreement at funeral
Freida Pinto asked to 'tone it down' while playing sexy princess
Bobbi Kristina 'appeared wasted' during mum Whitney Houston's burial
Reese Witherspoon wants more kids
Jennifer Aniston runs on adrenaline while shooting nude scenes
Emma Waston says people likened her pixie cut to that of lesbian's
Drew Barrymore sparks pregnancy rumours with visit to doctor

Read this article:
Darfur patrol returns home safely after rebel blockade

Diet Drug Qnexa Gets Thumbs-Up From FDA Panel

Posted: February 22, 2012 at 11:12 pm

Luis Pedrosa/iStockphoto.com

A new weight-loss pill could be coming to the menu.

A key federal panel Wednesday recommended the Food and Drug Administration approve the first new weight-loss drug in more than a decade.

At the conclusion of a day-long hearing, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 20-2 to endorse a request from Vivus to approve the drug Qnexa. The same panel gave a thumbs-down to Qnexa in 2010.

Qnexa is a combination of two generic drugs that are already on the market:

phentermine, a stimulant used for short periods to help control weight, and topiramate, typically used for migraines and seizures.

The FDA doesn't have to follow the advice of the panel, but the agency usually does.

 

The FDA rejected Qnexa in 2010 because of concerns about side effects, especially possible heart problems and birth defects such as cleft lips and cleft palates. The rejection came amid a series of rejections and withdrawals of weight-loss drugs, which put a spotlight on the FDA's handling of obesity medications.

Despite the obesity epidemic, the FDA hasn't approved a new weight-loss drug since 1999. In 2011, the the diet drug Meridia was pulled from the market at the request of the FDA because of concerns about heart problems. Only one weight-loss drug, Xenical, remains on the market for long-term use, but it is only marginally effective and causes diarrhea and other unpleasant side effects.

Some advocates have urged the FDA to consider allowing some drugs to be on the market even if they have risks, given the serious health problems caused by obesity.

During Wednesday's hearing, Vivus gave a series of presentations designed to show show that the benefits of the drug outweigh the risks. The risk of birth defects, one concern, was relatively low. And obesity itself can increase the danger that women will give birth to babies with birth defects, according to one presentation.

In addition, Qnexa appears to have other health benefits beyond weight loss, such as lowering blood pressure, that could outweigh any risks posed by an increase in the heart rate seen in some patients, according to another presentation.

Vivus also outlined a plan to reduce the risk that pregnant women might take Qnexa, including regular pregnancy testing of women taking the drug.

For its part, the FDA presented concerns it had highlighted in new analyses posted on its website Friday, especially the increased risks for birth defects and the elevated heart rate. The federal Centers for Disease Control and Prevention also presented data on the birth defect risk from topiramate.

During the public comment part of the hearing, several obesity experts urged the panel to recommend approval, saying diet and exercise simply do not work for many people.

Kelly Close, who described herself as an advocate for people with obesity and diabetes, urged the panel to endorse the drug. She noted few drugs were in the pipeline for obesity. "The panel and the FDA has a chance to today to do something historic for obesity," Close said.

Joe Nadglowski of the Obesity Action Coalition, agreed. He noted that only one member of the committee had any experience with treating obesity.

"There is a significant treatment gap from Weight Watchers to bariatric surgery," Nadglowski. "There is a consequence of remaining obese."

Several health advocates, however, appealed to the panel to recommend against the drug, saying the risks outweighed the benefits.

"Qnexa doesn't give women what they need," said Kate Ryan of the National Women's Health Network, noting that many people regain whatever weight they lose while taking Qnexa once they stop taking the drug.

See the rest here:
Diet Drug Qnexa Gets Thumbs-Up From FDA Panel

FDA Advisers Recommend New Diet Drug

Posted: February 22, 2012 at 11:12 pm

Food and Drug Administration advisers voted against the pleas of consumer advocates on Wednesday to recommend approval of what would be the first new diet drug to hit the US market in 13 years. Called Qnexa, the pill is a combination of two older drugs – one itself a diet pill called phentermine, and an anti-seizure drug that appears to help suppress appetite as part of the combination.

Such a new drug is desperately needed, with two-thirds of Americans overweight or obese. Current weight-loss products are limited and have only modest effects. But the field has been littered with failures, as many drugs have often deadly side effects – such as the heart valve damage caused by the once popular combination of phentermine and fenfluramine—Fen-Phen for short.

Two other companies have diet drugs up for approval too, and the FDA advisers recommended extra studies on the heart effects of all the drugs.

“Of all the obesity drugs, this one has the highest efficacy in terms of weight loss, so that shifts the balance in terms of requiring a post-approval study rather than a pre- approval study,” Sanjay Kaul, a cardiologist at UCLA, said at the FDA panel meeting.

Public Citizen objected.

“Public health cannot tolerate yet another drug approval for a diet drug not accurately assessed for cardiovascular risks, especially in light of suggestive findings of such risks with Qnexa,” said Dr. Sidney Wolfe, director of Public Citizen’s Health Research Group. “The danger of another approved diet drug hitting something vital – the cardiovascular system – is no longer acceptable when it could be prevented by a large clinical trial powered to evaluate such risk prior to approval.”

Read the original:
FDA Advisers Recommend New Diet Drug

Diet drug Qnexa should be approved, panel says

Posted: February 22, 2012 at 11:12 pm

The diet drug Qnexa has cleared a major hurdle toward eventual Food and Drug Administration approval. An independent panel of medical experts who advise the agency voted Wednesday that Qnexa's significant weight-loss benefit outweighed its potential risks.

The hearing was held in Silver Spring, Md. The surprisingly positive 20-2 vote in favor of approval moves the decision on Qnexa into the hands of the FDA, which will issue a final ruling later this year.

The agency typically follows the recommendations of an advisory committee but is not bound by it. If approved, as is now expected, Qnexa would be the first prescription diet drug to reach the market since 1999. The drug, made by Vivus Inc.of Mountain View, Calif., is a combination of the anticonvulsant topiramate and the appetite suppressant phentermine.

Studies show the medications produced an average of about 10% loss of body weight in the first two years of use. "The benefits of that degree of weight loss have been clear and unambiguous," said Dr. Stephen Smith, scientific director at the Translational Research Institute in Orlando, Fla., who was not involved in the vote. "We fully understand the topiramate risk, and the phentermine risk we have a pretty good handle on as well." The committee's vote, he said, "recognizes that doing nothing in obesity has it consequences."

More than 35% of American adults are obese and another third are overweight. Only one prescription diet drug is available in the United States. However, both topirimate and phentermine have side effects. Last year, the FDA reclassified topiramate as a class D drug, meaning it carries risks to a fetus but may still be acceptable for use in pregnant women despite the risks.

Clinical trials on Qnexa also showed an increased risk of birth defects -- typically cleft lip -- in women who became pregnant on the drug. The study also found that users have an increase in heart rate. These side effects led to a thumbs-down vote when Qnexa came before the FDA advisory committee in 2010. The FDA subsequently denied approval in October 2010, citing potential safety problems.

But officials for Vivus Inc. have proposed a tightly controlled system for prescribing Qnexa to prevent birth defects, including healthcare provider training, monthly pregnancy testing, a patient medication guide and limits on which pharmacies can dispense the medication, such as registered mail-order pharmacies.

"We will know who the prescribers are. We will know who has been trained," said Dr. Barbara Troupin, senior director of global medical affairs for Vivus. "We are confident the Qnexa [risk management program] balances the safeguards while allowing access for appropriate patients." Moreover, the panel strongly encouraged that Vivus conduct a post-marketing study to better understand the potential cardiovascular side effects of Qnexa.

Follow me: twitter.com/LATShariRoan

Visit link:
Diet drug Qnexa should be approved, panel says

WEIGHT LOSS TRANSFORMATIONS: WHY HIGH CARB LOW FAT WORKS – Video

Posted: February 22, 2012 at 11:12 pm

10-02-2012 23:15 WEIGHT LOSS TRANSFORMATIONS: WHY HIGH CARB LOW FAT WORKS Dietary thermogensis is the reason why 1000% of LONGTERM high carb low fat munchers are slim beans. Low carb HIGH FAT = High body fat and bad arteries. Hence why the majority of paleo, primal diet, low carb diet promoters have excess weight issues unless they are using steroids like is common in that scene unfortunately. Raw food diet vegan high carb low fat style based on fruit keeps you slim naturally. How to get a flat stomach, how to lose weight fast, how to lose weight with raw foods.how to start a raw food diet? all these questions and more answered by Durianrider and Freelee on our channels. Thanks for watching! 🙂 Durianrider on Facebook http://www.facebook.com To Donate to Durianrider: http://www.paypal.com Durianriders 2$ audio mp3 and blog links below. ?www.30bananasaday.com Blog ?www.durianrider.org? TAGS goal weight dream goal weight loss journey losing the fat weight watchers watch me shrink weight loss losing weight slim down baby fat shrinking calorie burning exercise calorie counting health and fitness diet and exercise diet and fitness diet bathing suit swimsuit before and after vegetarian raw food vegan durianrider freelea freelee

Go here to see the original:
WEIGHT LOSS TRANSFORMATIONS: WHY HIGH CARB LOW FAT WORKS - Video


Page 3,020«..1020..3,0193,0203,0213,022..3,0303,040..»